Valuation: ResMed Inc.

Market Cap 35.18B 189B 31.45B 28.96B 26.29B 49.2B 3,350B 50.08B 346B 138B 1,756B 132B 129B 5,549B P/E 2027 *
21.5x
P/E 2028 * 19.5x
Enterprise Value 34.18B 184B 30.56B 28.14B 25.54B 47.8B 3,254B 48.65B 336B 134B 1,706B 128B 126B 5,391B EV / Sales 2027 *
5.89x
EV / Sales 2028 * 5.44x
Free-Float
74.65%
Yield 2027 *
1.07%
Yield 2028 * 1.17%
1 day+20.76%
Current month+20.76%
1 month+20.76%
3 months+20.76%
6 months+5.80%
Current year-11.93%
1 month 238.41
Extreme 238.41
294.47
Current year 238.41
Extreme 238.41
357.02
1 year 238.41
Extreme 238.41
357.02
3 years 187.67
Extreme 187.67
397
5 years 183.79
Extreme 183.79
397
10 years 144.25
Extreme 144.25
397
Manager TitleAgeSince
Chief Executive Officer 54 28/02/2013
Director of Finance/CFO 41 03/05/2026
Chief Tech/Sci/R&D Officer - 31/01/2024
Director TitleAgeSince
Director/Board Member 78 31/12/2004
Chairman 54 24/01/2023
Chairman 84 31/05/1989
Change 5-day change 1-year change 3-year change Capi.($)
+20.76%0.00% - - 35.18B
+0.71%+2.18%+27.18%+64.39% 260B
+1.24%+1.33%+9.26%+26.13% 165B
+1.03%+4.82%-17.72%+73.28% 154B
+0.61%-4.09%-57.72%-13.79% 61.49B
+2.90%+6.83%+14.90%+53.04% 52.9B
+0.70%+2.83%-12.22%-6.48% 52.84B
-2.35%-3.19%+6.52%+63.75% 51.46B
-0.18%+1.91%+24.20%+76.27% 51.16B
+0.67%+4.94%+38.77%+96.14% 46.85B
Average +2.24%+1.34%+3.69%+48.08% 99.52B
Weighted average by Cap. +0.78%+1.41%+6.54%+50.97%

Financials

2027 *2028 *
Net sales 5.8B 31.25B 5.19B 4.78B 4.34B 8.12B 552B 8.26B 57.07B 22.74B 290B 21.78B 21.31B 915B 6.18B 33.27B 5.52B 5.09B 4.62B 8.64B 588B 8.79B 60.76B 24.22B 308B 23.18B 22.69B 974B
Net income 1.64B 8.83B 1.47B 1.35B 1.23B 2.29B 156B 2.33B 16.13B 6.43B 81.85B 6.16B 6.03B 259B 1.78B 9.59B 1.59B 1.47B 1.33B 2.49B 170B 2.54B 17.52B 6.98B 88.88B 6.68B 6.54B 281B
Net Debt -1B -5.4B -896M -825M -749M -1.4B -95.41B -1.43B -9.86B -3.93B -50B -3.76B -3.68B -158B -1.56B -8.38B -1.39B -1.28B -1.16B -2.18B -148B -2.21B -15.3B -6.1B -77.62B -5.84B -5.71B -245B
Projected Income Statement - Annual - ResMed Inc.
Logo ResMed Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.2%); - masks (36.9%); - software as a service (11.9%): residential care management software solutions. At the end of June 2026, the group had 9 production sites located in the United States (4), Australia, China, Singapore, Malaysia and France. The United States accounts for 63% of net sales.
Employees
11,370
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - ResMed Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
252.83USD
Average target price
251.52USD
Spread / Average Target
-0.52%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ResMed Inc.